Literature DB >> 15120821

Predictors of stroke in patients paced for sick sinus syndrome.

Arnold J Greenspon1, Robert G Hart, David Dawson, Anne S Hellkamp, Marc Silver, Greg C Flaker, Eleanor Schron, Lee Goldman, Kerry L Lee, Gervasio A Lamas.   

Abstract

OBJECTIVES: This study was an analysis of factors associated with stroke in a population of patients paced for sinus node dysfunction in a large prospective clinical trial (Mode Selection Trial [MOST]).
BACKGROUND: The effects of dual-chamber versus single-chamber ventricular pacing on subsequent stroke in patients with sinus node dysfunction are not known.
METHODS: A total of 2,010 patients with sinus node dysfunction were randomized to ventricular or dual-chamber pacing and followed for a median of 33.1 months.
RESULTS: The median participant age was 74 years. During 5,664 patient-years of follow-up, 90 strokes (11 hemorrhagic) occurred. By life-table analysis, the rate of stroke was 2.2% (95% confidence interval [CI] 1.6 to 2.9) at one year and 5.8% (95% CI 4.5 to 7.1) at four years. The incidence of stroke was not significantly different in dual-chamber (4%) as compared with ventricular-paced patients (4.9%) (hazard ratio [HR] 0.82, 95% CI 0.54 to 1.25, p = 0.36). Multivariable analysis demonstrated that significant predictors of stroke included prior stroke or transient ischemic attack, Caucasian race, hypertension, prior systemic embolism, and New York Heart Association functional class III or IV (p < 0.05); pacing mode remained non-significant after adjustment for these factors (p = 0.37). Clinically reported atrial fibrillation after implantation was a risk factor for stroke in this cohort after adjustment for other predictors of stroke (p = 0.042, HR 1.68 [95% CI 1.02 to 2.76]).
CONCLUSIONS: Clinical characteristics, but not mode of pacing, were associated with subsequent stroke in patients paced for sinus node dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120821     DOI: 10.1016/j.jacc.2003.09.067

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy.

Authors:  Simon Pecha; Ayhan Ayikli; Iris Wilke; Samer Hakmi; Yalin Yildirim; Nils Gosau; Hermann Reichenspurner; Stephan Willems; Muhammet Ali Aydin
Journal:  Heart Vessels       Date:  2017-10-13       Impact factor: 2.037

2.  Long-term outcome of single-chamber atrial pacing compared with dual-chamber pacing in patients with sinus-node dysfunction and intact atrioventricular node conduction.

Authors:  Won Ho Kim; Boyoung Joung; Jaemin Shim; Jong Sung Park; Eui-Seock Hwang; Hui-Nam Pak; Sungsoon Kim; Moonhyoung Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

3.  Antithrombotic therapy in cardiac embolism.

Authors:  Alvaro Cervera; Angel Chamorro
Journal:  Curr Cardiol Rev       Date:  2010-08

4.  Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study.

Authors:  Taya V Glotzer; Emile G Daoud; D George Wyse; Daniel E Singer; Reece Holbrook; Khadeeja Pruett; Kenneth Smith; Christopher E Hilker
Journal:  J Interv Card Electrophysiol       Date:  2006-01       Impact factor: 1.759

5.  Antithrombotic medication for cardioembolic stroke prevention.

Authors:  M Àngels Font; Jerzy Krupinski; Adrià Arboix
Journal:  Stroke Res Treat       Date:  2011-06-22

6.  Incidence, predictors and outcomes of hematoma after ICD implantation: An analysis of a nationwide database of 85,276 patients.

Authors:  Arun Raghav Mahankali Sridhar; Vivek Yarlagadda; Arun Kanmanthareddy; Sravanthi Parasa; Ryan Maybrook; Buddhadeb Dawn; Yeruva Madhu Reddy; Dhanunjaya Lakkireddy
Journal:  Indian Pacing Electrophysiol J       Date:  2016-10-21

7.  Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation.

Authors:  Emma Sandgren; Cecilia Rorsman; Nils Edvardsson; Johan Engdahl
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

8.  Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator.

Authors:  Elif Kaya; Johannes Siebermair; Obayda Azizy; Dobromir Dobrev; Tienush Rassaf; Reza Wakili
Journal:  Int J Cardiol Heart Vasc       Date:  2019-07-05

9.  CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome.

Authors:  Jesper Hastrup Svendsen; Jens Cosedis Nielsen; Stine Darkner; Gunnar Vagn Hagemann Jensen; Leif Spange Mortensen; Henning Rud Andersen
Journal:  Heart       Date:  2013-03-28       Impact factor: 5.994

10.  Junctional bradycardia is a potential risk factor of stroke.

Authors:  Gwang Sil Kim; Jae-Sun Uhm; Tae-Hoon Kim; Hancheol Lee; Junbeom Park; Jin-Kyu Park; Boyoung Joung; Hui-Nam Pak; Moon-Hyoung Lee
Journal:  BMC Neurol       Date:  2016-07-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.